BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3724934)

  • 1. Effect of nifedipine on urinary calcium and oxalate excretion in renal stone formers.
    Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
    Nephron; 1986; 43(3):234-5. PubMed ID: 3724934
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of nifedipine on kidney output of calcium, oxalic acid, and saturation of urinary calcium oxalate].
    Pupek-Musialik D; Głuszek J
    Pol Tyg Lek; 1991 Jan 21-28; 46(4-5):74-5. PubMed ID: 1845698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
    Brown JM; Stratmann G; Cowley DM; Mottram BM; Chalmers AH
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of citrate on the urinary excretion of calcium and oxalate: relevance to calcium oxalate nephrolithiasis.
    Cowley DM; McWhinney BC; Brown JM; Chalmers AH
    Clin Chem; 1989 Jan; 35(1):23-8. PubMed ID: 2910576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
    Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of oxalate by patients with renal hypercalciuric stone disease. Effect of chronic treatment with hydrochlorothiazide.
    Urivetzky M; Braverman S; Motola JA; Smith AD
    Urology; 1991 Apr; 37(4):327-30. PubMed ID: 2014597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary intake on urinary oxalate excretion in calcium oxalate stone formers in their forties.
    Naya Y; Ito H; Masai M; Yamaguchi K
    Eur Urol; 2000 Feb; 37(2):140-4. PubMed ID: 10705190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of fenquizone on the urinary inhibitors of calcium oxalate urolithiasis.
    Cupisti A; Ciardella F; Morelli E; Dani L; Lupetti S; Luchi S; Meola M; Barsotti G
    Contrib Nephrol; 1987; 58():184-6. PubMed ID: 3691123
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridoxine therapy in patients with renal calcium oxalate calculi.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Minar E
    Proc Eur Dial Transplant Assoc; 1983; 20():417-21. PubMed ID: 6657665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-carbon oxalogenesis compared in recurrent calcium oxalate stone formers and normal subjects.
    McWhinney BC; Nagel SL; Cowley DM; Brown JM; Chalmers AH
    Clin Chem; 1987 Jul; 33(7):1118-20. PubMed ID: 3594837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does sucrose damage kidneys?
    Li MK; Kavanagh JP; Prendiville V; Buxton A; Moss DG; Blacklock NJ
    Br J Urol; 1986 Aug; 58(4):353-7. PubMed ID: 3756399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine oxalate and calcium in idiopathic renal stone formers.
    Wallace MR; Mason K; Gray J
    N Z Med J; 1981 Aug; 94(689):87-9. PubMed ID: 6944647
    [No Abstract]   [Full Text] [Related]  

  • 19. Circadian variations of blood and urinary constituents in renal stone formers.
    Singh RK; Bansal A; Bansal SK; Rai SP
    Prog Clin Biol Res; 1990; 341B():551-7. PubMed ID: 2217342
    [No Abstract]   [Full Text] [Related]  

  • 20. Age and sex as factors in oxalic acid excretion in healthy persons and calcium oxalate stone patients.
    Hesse A; Klocke K; Classen A; Vahlensieck W
    Contrib Nephrol; 1987; 58():16-20. PubMed ID: 3691119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.